Work productivity in patients with axial spondyloarthritis initiating biological or targeted synthetic disease-modifying antirheumatic drugs: a systematic literature review and meta-analysis

BACKGROUND: Axial spondyloarthritis (axSpA) can limit work participation. Our objective was to characterise productivity in patients with axSpA, including changes after 12–16 weeks of treatment with biological and targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs). METHODS: A syst...

Descripción completa

Detalles Bibliográficos
Autores principales: Rudwaleit, Martin, Mørup, Michael F, Humphries, Brittany, Zannat, Noor-E, Willems, Damon, Taieb, Vanessa, Boonen, Annelies
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689353/
https://www.ncbi.nlm.nih.gov/pubmed/38035757
http://dx.doi.org/10.1136/rmdopen-2023-003468

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10689353/
https://www.ncbi.nlm.nih.gov/pubmed/38035757
http://dx.doi.org/10.1136/rmdopen-2023-003468

Ejemplares similares